Hovione Loures

Manufacturing Plant

The site was first approved by the FDA in 1982, and is regularly inspected.

Manufacturing Plant in Portugal | Hovione

Hovione Loures has been operational since 1969. The site has grown continually as upgraded facilities have been added. The plant was first approved by the FDA in 1982, and is regularly inspected.

The site has an extensive capacity for drug substance manufacturing and particle engineering. Hovione Loures can support the development, piloting and full commercialization of your drug substance and drug product intermediate based on an available capacity of 430 cubic meters of vessels, ranging from 50 to 14,000lt, complemented with a full range of spray dryers, from lab scale to industrial sizes.

The site houses a large and well qualified Process Development and Analytical Development team in the areas of Drug Substance, Particle Engineering and Drug Product.

Areas of Focused Expertise

The site has world class capabilities and physical assets in the following areas:

For details about production equipment – click here

Operations

  • The Loures plant operates 24 hours a day 7 days a week.
  • Quality Control labs support production 24 hours a day 7 days a week.
  • Plant maintenance shutdown period takes place for 3 weeks in August.

Certifications

The site has an Health, Safety and Environment Management System in accordance with OHSAS18001 and ISO14001. The system is periodically audited and reviewed and is ISO14001 and OHSAS18001 certified.

The site is a certified Authorized Economic Operator.

Hovione FarmaCiencia SA is a member of the BCSD Portugal which reflects our commitment to work for a more sustainable business.

 

For inquiries about Hovione Loures, kindly fill the form below.

News

Lisbon, Portugal – Hovione, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, Hovione joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At Hovione, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of Hovione. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” Hovione will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with Hovione’s sustainability ambitions.  Hovione remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024
Manufacturing Plant
Address

Hovione Farmaciência S.A.
Sete Casas
2674-506 Loures
Portugal
Tel.: +351 21 982 9000
Fax: +351 21 982 9388
Email: contact@hovione.com
DUNS Nr: 449818434
Location: 38°50'33.526" N 9°10'42.240" W

Other Locations

Hovione Hong Kong

Office
Address

Hovione Holding Asia Limited
Aubin House, 11th Floor
171-172 Gloucester Road
Wanchai
Hong Kong SAR
Tel.: +852 2891 1836
Fax: +852 2891 0943 

Hovione India

Office
Address

Hovione Holding Limited
C/o WeWork, 2nd floor,
Oberoi Commerz - II,  1,
Off Western Express Highway,
Oberoi Garden City, Goregaon East, Mumbai, Maharashtra 400063
India
Tel.: +919 004 261 523

Hovione Beijing

Office
Address

Hovione (Shanghai) Pharma Technology Limited Beijing Branch
Room 1003-1, 10/F, Sanyuan NEO Xinjing Building, Building 18, No. 5 Shuguang Xili, Chaoyang District, Beijing, China
Tel.: +86-18500027185
Tel.: +86-19931153253 

contact@hovione.com